{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:41:21Z","timestamp":1790937681629,"version":"4.1.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2008,11,4]],"date-time":"2008-11-04T00:00:00Z","timestamp":1225756800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0003636","type":"journal-article","created":{"date-parts":[[2008,11,4]],"date-time":"2008-11-04T00:28:18Z","timestamp":1225758498000},"page":"e3636","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["HIV-1 Disease-Influencing Effects Associated with ZNRD1, HCP5 and HLA-C Alleles Are Attributable Mainly to Either HLA-A10 or HLA-B*57 Alleles"],"prefix":"10.1371","volume":"3","author":[{"given":"Gabriel","family":"Catano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent C.","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Agan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Landrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Delmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Telles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Castiblanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,11,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1056\/NEJMra066267","article-title":"An HIV vaccine\u2013evolving concepts.","volume":"356","author":"MI Johnston","year":"2007","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nm0304-221","article-title":"Prospects for an AIDS vaccine.","volume":"10","author":"RC Desrosiers","year":"2004","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.1152622","article-title":"Toward an AIDS vaccine.","volume":"320","author":"BD Walker","year":"2008","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.1154258","article-title":"AIDS\/HIV. A STEP into darkness or light?","volume":"320","author":"JP Moore","year":"2008","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20072681","article-title":"The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?","volume":"205","author":"RP Sekaly","year":"2008","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1126\/science.318.5847.28","article-title":"AIDS research. Promising AIDS vaccine's failure leaves field reeling.","volume":"318","author":"J Cohen","year":"2007","journal-title":"Science"},{"key":"ref7","article-title":"AIDS Vaccine Trials:Considerations for Phase III Trial Design and Endpoints N, NIH, Nov. 16, 2001, http:\/\/www.niaid.nih.gov\/vrc\/pdf\/p3trialsend.pdf"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/376449","article-title":"What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials.","volume":"188","author":"PB Gilbert","year":"2003","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/1541-0420.00063","article-title":"Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials.","volume":"59","author":"PB Gilbert","year":"2003","journal-title":"Biometrics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1086\/510909","article-title":"Estimating the benefit of an HIV-1 vaccine that reduces viral load set point.","volume":"195","author":"SB Gupta","year":"2007","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1071\/SH04057","article-title":"Genetic influences on HIV infection: implications for vaccine development.","volume":"2","author":"MZ Smith","year":"2005","journal-title":"Sex Health"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.med.54.101601.152346","article-title":"The influence of HLA genotype on AIDS.","volume":"54","author":"M Carrington","year":"2003","journal-title":"Annu Rev Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm1333","article-title":"AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis.","volume":"11","author":"X Gao","year":"2005","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.it.2004.11.001","article-title":"HIV-1 diversity versus HLA class I polymorphism.","volume":"26","author":"HA Stephens","year":"2005","journal-title":"Trends Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1086\/425269","article-title":"Influence of host genetic variation on susceptibility to HIV type 1 infection.","volume":"191","author":"RA Kaslow","year":"2005","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nri2357","article-title":"Impact of MHC class I diversity on immune control of immunodeficiency virus replication.","volume":"8","author":"PJ Goulder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/COH.0b013e3282fbaa92","article-title":"Host genetic determinants of HIV pathogenesis: an immunologic perspective. Immune correlates of protection, activation and exhaustion.","volume":"3","author":"P Hunt","year":"2008","journal-title":"Current Opinion in HIV & AIDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/COH.0b013e3282f18ac0","article-title":"Host factors associated with outcome from primary human immunodeficiency virus-1 infection. .","volume":"3","author":"A Telenti","year":"2008","journal-title":"Current Opinion in HIV & AIDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1073\/pnas.050567397","article-title":"HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.","volume":"97","author":"SA Migueles","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1128\/JVI.77.12.6889-6898.2003","article-title":"The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.","volume":"77","author":"SA Migueles","year":"2003","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1097\/00002030-200312050-00005","article-title":"Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.","volume":"17","author":"M Altfeld","year":"2003","journal-title":"Aids"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.4049\/jimmunol.179.5.3133","article-title":"Viral replication capacity as a correlate of HLA B57\/B5801-associated nonprogressive HIV-1 infection.","volume":"179","author":"M Navis","year":"2007","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1086\/425267","article-title":"Potential public health impact of imperfect HIV type 1 vaccines.","volume":"191","author":"R Anderson","year":"2005","journal-title":"J Infect Dis"},{"key":"ref24","first-page":"113","article-title":"Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.","volume":"5","author":"S Blower","year":"2003","journal-title":"AIDS Rev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/QAI.0b013e3180959a94","article-title":"Analytic insights into the population level impact of imperfect prophylactic HIV vaccines.","volume":"45","author":"LJ Abu-Raddad","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.qai.0000230526.79341.83","article-title":"Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa.","volume":"43","author":"S Amirfar","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.1143767","article-title":"A whole-genome association study of major determinants for host control of HIV-1.","volume":"317","author":"J Fellay","year":"2007","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.","volume":"126","author":"JW Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.272.5265.1167","article-title":"Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.","volume":"272","author":"JW Mellors","year":"1996","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.gene.6364256","article-title":"Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression.","volume":"6","author":"S Gaudieri","year":"2005","journal-title":"Genes Immun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2007.08.010","article-title":"Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.","volume":"27","author":"SG Deeks","year":"2007","journal-title":"Immunity"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ng1885","article-title":"A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.","volume":"38","author":"PI de Bakker","year":"2006","journal-title":"Nat Genet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/429393","article-title":"A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms.","volume":"76","author":"MM Miretti","year":"2005","journal-title":"Am J Hum Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"12004","DOI":"10.1073\/pnas.96.21.12004","article-title":"Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.","volume":"96","author":"E Gonzalez","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1093\/hmg\/ddh075","article-title":"Patterns of ethnic diversity among the genes that influence AIDS.","volume":"13 Spec No 1","author":"C Winkler","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1073\/pnas.091056898","article-title":"Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.","volume":"98","author":"E Gonzalez","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.1101160","article-title":"The influence of CCL3L1 gene-containing segmental duplications on HIV-1\/AIDS susceptibility.","volume":"307","author":"E Gonzalez","year":"2005","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm1741","article-title":"CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.","volume":"14","author":"SK Ahuja","year":"2008","journal-title":"Nat Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ni1521","article-title":"CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.","volume":"8","author":"MJ Dolan","year":"2007","journal-title":"Nat Immunol"},{"key":"ref40","first-page":"119","article-title":"Immunobiology of HLA;","author":"V Joysey","year":"1989"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1086\/320705","article-title":"Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus.","volume":"183","author":"A Mangano","year":"2001","journal-title":"J Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1128\/JVI.00800-08","article-title":"Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.","volume":"82","author":"JR Bailey","year":"2008","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.chom.2008.06.002","article-title":"Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.","volume":"4","author":"W He","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jama.296.12.1498","article-title":"Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.","volume":"296","author":"B Rodriguez","year":"2006","journal-title":"Jama"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.296.12.1523","article-title":"Explaining, predicting, and treating HIV-associated CD4 cell loss: after 25 years still a puzzle.","volume":"296","author":"WK Henry","year":"2006","journal-title":"Jama"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1471-4914(01)02131-1","article-title":"HLA and AIDS: a cautionary tale.","volume":"7","author":"SJ O'Brien","year":"2001","journal-title":"Trends Mol Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1099\/0022-1317-77-8-1659","article-title":"Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1.","volume":"77 (Pt 8)","author":"CA van Baalen","year":"1996","journal-title":"J Gen Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00002030-199603000-00023","article-title":"Identification of a novel HLA-A25-restricted epitope in a conserved region of p24 gag (positions 71-80).","volume":"10","author":"P Klenerman","year":"1996","journal-title":"Aids"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1386-6532(02)00109-9","article-title":"Definition of two new epitopes on human immunodeficiency virus type 1 gag protein recognized by human CD8+ cytotoxic T lymphocyte clones.","volume":"27","author":"I Kurane","year":"2003","journal-title":"J Clin Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/00002030-199610000-00025","article-title":"Identification of a novel human leukocyte antigen A26-restricted epitope in a conserved region of Gag.","volume":"10","author":"P Goulder","year":"1996","journal-title":"Aids"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.1152725","article-title":"Identification of host proteins required for HIV infection through a functional genomic screen.","volume":"319","author":"AL Brass","year":"2008","journal-title":"Science"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/QAD.0b013e3282f470e4","article-title":"The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors.","volume":"22","author":"Y Han","year":"2008","journal-title":"Aids"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1084\/jem.20052319","article-title":"Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.","volume":"203","author":"JR Bailey","year":"2006","journal-title":"J Exp Med"},{"key":"ref54","first-page":"199","article-title":"A genome-wide association study in HIV Elite Controllers to identify host genetic factors that influence viral control in the absence of anti-retroviral therapy.","author":"PIW de Bakker","year":"2008","journal-title":"Abstract in Keystone Symposia on Molecular and Cellular Biology, Banff, Alberta, Canada Section of HIV Pathogenesis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.gene.6364315","article-title":"Conserved extended haplotypes of the major histocompatibility complex: further characterization.","volume":"7","author":"MT Dorak","year":"2006","journal-title":"Genes Immun"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.4049\/jimmunol.181.4.2626","article-title":"Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples.","volume":"181","author":"J Tang","year":"2008","journal-title":"J Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e1000041","DOI":"10.1371\/journal.pgen.1000041","article-title":"A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease Loci.","volume":"4","author":"Y Liu","year":"2008","journal-title":"PLoS Genet"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1172\/JCI33034","article-title":"Understanding the benign nature of SIV infection in natural hosts.","volume":"117","author":"G Silvestri","year":"2007","journal-title":"J Clin Invest"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"13795","DOI":"10.1073\/pnas.202357499","article-title":"HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.","volume":"99","author":"E Gonzalez","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1086\/588712","article-title":"Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations.","volume":"198","author":"G Catano","year":"2008","journal-title":"J Infect Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1073\/pnas.0803526105","article-title":"Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4\/epsilon4 genotype accelerates HIV disease progression.","volume":"105","author":"TD Burt","year":"2008","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0003636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:02:49Z","timestamp":1589022169000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0003636"}},"subtitle":[],"editor":[{"given":"Esper Georges","family":"Kallas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,11,4]]},"references-count":61,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2008,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0003636","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,4]]}}}